Prudential Financial’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-12,645
| Closed | -$52K | – | 2796 |
|
|
2022
Q1 | $52K | Hold |
12,645
| – | – | ﹤0.01% | 2573 |
|
|
2021
Q4 | $45K | Sell |
12,645
-7,102
| -36% | -$24.8K | ﹤0.01% | 2603 |
|
|
2021
Q3 | $72K | Sell |
19,747
-24,895
| -56% | -$101K | ﹤0.01% | 2542 |
|
|
2021
Q2 | $195K | Buy |
44,642
+26,569
| +147% | +$108K | ﹤0.01% | 2458 |
|
|
2021
Q1 | $74K | Sell |
18,073
-754
| -4% | -$3.27K | ﹤0.01% | 2449 |
|
|
2020
Q4 | $75K | Sell |
18,827
-40,310
| -68% | -$130K | ﹤0.01% | 2400 |
|
|
2020
Q3 | $160K | Buy |
59,137
+6,770
| +13% | +$18.7K | ﹤0.01% | 2317 |
|
|
2020
Q2 | $144K | Buy |
52,367
+34,545
| +194% | +$96.4K | ﹤0.01% | 2302 |
|
|
2020
Q1 | $42K | Sell |
17,822
-1,925
| -10% | -$6.55K | ﹤0.01% | 2311 |
|
|
2019
Q4 | $93K | Buy |
19,747
+5,057
| +34% | +$20.7K | ﹤0.01% | 2381 |
|
|
2019
Q3 | $49K | Sell |
14,690
-3,840
| -21% | -$12.6K | ﹤0.01% | 2382 |
|
|
2019
Q2 | $61K | Buy |
18,530
+4,680
| +34% | +$13.5K | ﹤0.01% | 2414 |
|
|
2019
Q1 | $42K | Hold |
13,850
| – | – | ﹤0.01% | 2408 |
|
|
2018
Q4 | $38K | Buy |
13,850
+190
| +1% | +$626 | ﹤0.01% | 2341 |
|
|
2018
Q3 | $46K | Sell |
13,660
-610
| -4% | -$1.88K | ﹤0.01% | 2399 |
|
|
2018
Q2 | $37K | Hold |
14,270
| – | – | ﹤0.01% | 2412 |
|
|
2018
Q1 | $31K | Hold |
14,270
| – | – | ﹤0.01% | 2329 |
|
|
2017
Q4 | $28K | Sell |
14,270
-27,670
| -66% | -$60.2K | ﹤0.01% | 2323 |
|
|
2017
Q3 | $136K | Buy |
41,940
+27,350
| +187% | +$84.4K | ﹤0.01% | 2284 |
|
|
2017
Q2 | $47K | Buy |
+14,590
| New | +$41.4K | ﹤0.01% | 2322 |
|
|
2016
Q1 | – | Sell |
-13,591
| Closed | -$16K | – | 2341 |
|
|
2015
Q4 | $16K | Sell |
13,591
-700
| -5% | -$974 | ﹤0.01% | 2226 |
|
|
2015
Q3 | $24K | Buy |
14,291
+500
| +4% | +$980 | ﹤0.01% | 2204 |
|
|
2015
Q2 | $29K | Buy |
13,791
+1,500
| +12% | +$3.64K | ﹤0.01% | 2215 |
|
|
2015
Q1 | $33K | Hold |
12,291
| – | – | ﹤0.01% | 2212 |
|
|
2014
Q4 | $32K | Buy |
+12,291
| New | +$27.6K | ﹤0.01% | 2180 |
|
|
2014
Q3 | – | Sell |
-16,144
| Closed | -$43K | – | 2337 |
|
|
2014
Q2 | $43K | Buy |
16,144
+5,353
| +50% | +$16.1K | ﹤0.01% | 2392 |
|
|
2014
Q1 | $38K | Sell |
10,791
-400
| -4% | -$1.77K | ﹤0.01% | 2238 |
|
|
2013
Q4 | $50K | Sell |
11,191
-500
| -4% | -$2.04K | ﹤0.01% | 2257 |
|
|
2013
Q3 | $47K | Buy |
11,691
+400
| +4% | +$1.75K | ﹤0.01% | 2249 |
|
|
2013
Q2 | $47K | Buy |
+11,291
| New | +$43.6K | ﹤0.01% | 2254 |
|
Other funds holding ATRS
Prudential Financial's ATRS Position: Q2 2022 in Review
Prudential Financial sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 12,645 shares — an estimated $52K sold.
Prudential Financial first reported a position in ATRS in Q2 2013 and held it in 30 quarters. The position peaked at $195K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Prudential Financial reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Prudential Financial sold 12,645 Antares Pharma, Inc. shares in Q2 2022, an estimated $52K.
- Prudential Financial first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 30 quarters.
- Prudential Financial's Antares Pharma, Inc. position peaked at $195K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Prudential Financial's 13F filing for Q2 2022, filed 15 Aug 2022.